Neoadjuvant chemotherapy of bevacizumab, gemcitabine and cisplatin in stage IIIA NSCLC
Latest Information Update: 24 Apr 2016
Price :
$35 *
At a glance
- Drugs Bevacizumab (Primary) ; Cisplatin; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 14 Aug 2012 New trial record